To CANCER IMMUNITY Home Page

Figure 1

Response to ipilimumab therapy of patient case 1. Visible lesions at (A) baseline were reduced after (B) 7 and (C) 12 weeks of ipilimumab therapy. Palpable tumors flattened and disappeared over the course of therapy, leaving behind a "tattoo" of residual melanin pigment.

 

Copyright © 2008 by Jedd D. Wolchok